Back to search

United States· US:87267-012_5438682c-6bc6-83f2-e063-6394a90ac348

DRMITSUI HYDROCOLLOID WOUND

A medicinal product containing carboxymethylcellulose, registered in United States by YIYANGYUAN LIFE SCIENCES (HONG KONG) CO., LIMITED.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDRMITSUI HYDROCOLLOID WOUNDATC—REGISTER NO.US:87267-012_5438682c…PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CARBOXYMETHYLCELLULOSE
Manufacturer
YIYANGYUAN LIFE SCIENCES (HONG KONG) CO., LIMITED
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    87267-012-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Carboxymethylcellulose in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carboxymethylcellulose products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Czechia · Cellufluid
  • Denmark · Celluvisc
  • Spain · Carmelosa Qualigen, Carmelosa Stada
  • Finland · Celluvisc
  • France · Celluvisc
  • United Kingdom (Northern Ireland) · Celluvisc
  • Greece · Refresh Plus
  • Ireland · Celluvisc
  • Italy · Celluvisc
  • Netherlands · Cellufluid, Celluvisc
  • Portugal · Celluvisc
  • Sweden · Cellufluid, Celluvisc
  • Slovakia · Cellufluid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9889ae30-89e5-476e-8dcb-1b36ea093308
GET /v1/drugs/9889ae30-89e5-476e-8dcb-1b36ea093308?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "60",
  "substance": "CARBOXYMETHYLCELLULOSE",
  "productndc": "87267-012",
  "dosage_form": "PATCH",
  "dea_schedule": null,
  "strength_unit": "g/100g",
  "application_number": "505G(a)(3)",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about carboxymethylcellulose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.